SEL1L expression decreases breast tumor cell aggressiveness in vivo and in vitroORLANDI, Rosaria; CATTANEO, Monica; TROGLIO, Flavia et al.Cancer research (Baltimore). 2002, Vol 62, Num 2, pp 567-574, issn 0008-5472Article

HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviorsMENARD, Sylvie; BALSARI, Andrea; CASALINI, Patrizia et al.Clinical cancer research. 2002, Vol 8, Num 2, pp 520-525, issn 1078-0432Article

SPARC Oppositely Regulates Inflammation and Fibrosis in Bleomycin-Induced Lung DamageSANGALETTI, Sabina; TRIPODO, Claudio; COLOMBO, Mario P et al.The American journal of pathology. 2011, Vol 179, Num 6, pp 3000-3010, issn 0002-9440, 11 p.Article

Immunological and pathobiological roles of fibulin-1 in breast cancerPUPA, Serenella M; ARGRAVES, Scott W; MORTARINI, Roberta et al.Oncogene (Basingstoke). 2004, Vol 23, Num 12, pp 2153-2160, issn 0950-9232, 8 p.Article

Maspin influences response to doxorubicin by changing the tumor microenvironment organizationTRIULZI, Tiziana; RATTI, Manuela; BALSARI, Andrea et al.International journal of cancer (Print). 2014, Vol 134, Num 12, pp 2789-2797, issn 0020-7136, 9 p.Article

HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancerMOLITERNI, Angela; MENARD, Sylvie; BONADONNA, Gianni et al.Journal of clinical oncology. 2003, Vol 21, Num 3, pp 458-462, issn 0732-183X, 5 p.Article

Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variablesMENARD, Sylvie; VALAGUSSA, Pinuccia; CASCINELLI, Natale et al.Journal of clinical oncology. 2001, Vol 19, Num 2, pp 329-335, issn 0732-183XArticle

MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancerIORIO, Marilena V; CASALINI, Patrizia; TAGLIABUE, Elda et al.European journal of cancer (1990). 2008, Vol 44, Num 18, pp 2753-2759, issn 0959-8049, 7 p.Article

Linking survival of HER2-positive breast carcinoma patients with surgical invasivenessTAGLIABUE, Elda; AGRESTI, Roberto; CASALINI, Patrizia et al.European journal of cancer (1990). 2006, Vol 42, Num 8, pp 1057-1061, issn 0959-8049, 5 p.Article

Functional Mapping of Receptor Tyrosine Kinases in Myxoid LiposarcomaNEGRI, Tiziana; VIRDIS, Emanuela; CASALINI, Patrizia et al.Clinical cancer research (Print). 2010, Vol 16, Num 14, pp 3581-3593, issn 1078-0432, 13 p.Article

microRNA-205 Regulates HER3 in Human Breast CancerLORIO, Marilena V; CASALINI, Patrizia; PIOVAN, Claudia et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 6, pp 2195-2200, issn 0008-5472, 6 p.Article

Two Distinct Local Relapse Subtypes in Invasive Breast Cancer : Effect on their Prognostic ImpactCASALINI, Patrizia; CARCANGIU, Maria Luisa; TAMMI, Raija et al.Clinical cancer research. 2008, Vol 14, Num 1, pp 25-31, issn 1078-0432, 7 p.Article

Redirected activity of human antitumor chimeric immune receptors is governed by antigen and receptor expression levels and affinity of interactionTURATTI, Fabio; FIGINI, Mariangela; BALLADORE, Emanuela et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 7, pp 684-693, issn 1524-9557, 10 p.Article